Skip to main content
. 2025 Dec 23;100(2):927–934. doi: 10.1038/s41390-025-04551-7

Table 1.

Baseline characteristics and hormone levels of the study population

Total Girls Boys P-value
Anthropometrics
 n (%) 485 218 (45) 267 (55)
 Age (years) 10.80 [9.56, 12.61] 10.71 [9.73, 12.44] 10.84 [9.46, 12.78] 0.870
 Height (cm) 146.0 [137.9,157.0] 146[137.2, 156.4] 146.5 [138.5, 159.25] 0.226
 Weight (kg) 36.70 [31.58, 45.90] 36.00 [31.18, 44.17] 36.70 [31.45, 45.80] 0.431
 BMI (kg/m2) 17.20 [15.70, 18.90] 17.30 [15.70, 19.00] 17.00 [15.60, 18.60] 0.498
 BMI z-score −0.08 (1.05) −0.01 (1.01) −0.16 (1.08) 0.076
 Waist circumf. (cm) 63.50 [59.0, 70.00] 63.0 (58.4, 68.6) 64.0 [59.0, 70.0] 0.460
 Waist circumf. z-score 0.14 (1.08) 0.26 (1.09) 0.04 (1.06) 0.051
 Total fat mass % (DXA) 20.28 [15.10, 27.01] 24.21 [19.84, 29.85] 16.25 [11.97, 21.98] <0.001
Puberty
 Pubertal (T2-5), n (%) 273 (61.3) 110 (53.9) 163 (67.6) 0.001
Lipids
 HDL (mg/dL) 1.58 [1.34, 1.89] 1.55 [1.37, 1.84] 1.60 [1.34, 1.91] 0.565
 LDL (mg/dL) 2.25 [1.89, 2.69] 2.43 [2.07, 2.79] 2.17 [1.78, 2.56] <0.001
 Triglycerides (mg/dL) 0.58 [0.47, 0.76] 0.63 [0.52, 0.82] 0.54 [0.45, 0.70] <0.001
 Total cholesterol (mg/dL) 4.24 [3.75, 4.65] 4.37 [3.94, 4.75] 4.14 [3.63, 4.55] <0.001
Biomarkers
 GLP-1 (pmol/L) 4.64 [3.81, 5.65] 4.56 [3.65, 5.61] 4.73 [3.89, 5.65] 0.385
 GIP (pg/mL) 113.27 [83.89, 151.88] 117.18 [83.91, 157.97] 111.89 [83.93, 147.52] 0.603
 Glucagon (pmol/L) 6.10 [4.99, 7.67] 5.95 [4.77, 7.44] 6.27 [5.07, 7.86] 0.121
 Insulin (microIU/ml) 4.20 [2.95, 5.80] 4.80 [3.60, 6.58] 3.60 [2.70, 5.50] <0.001
 Fasting Plasma glucose (mg/dl) 5.00 [4.73, 5.30] 5.00 [4.70, 5.30] 5.10 [4.80, 5.40] 0.045
Insulin resistance
 HOMA IR 1.10 (0.75) 1.20 (0.63) 1.02 (0.83) 0.011
 HOMA2-IR 0.55 (0.33) 0.60 (0.30) 0.50 (0.35) <0.001

Data presented as median [interquartile range] and mean (SD) for continuous variables depending on distribution and frequencies (percentage; %) for categorical variables. P values were determined by Wilcoxon rank sum tests for continuous data and chi-square tests for categorical data. Statistically significant results are in bold.

BMI body mass index, WC waist circumference, HDL high-density lipoprotein, LDL low-density lipoprotein, GLP-1 glucagon-like peptide 1, GIP glucose-dependent insulinotropic polypeptide, HOMA-IR Homeostatic Model Assessment 2 for Insulin Resistance, HOMA2-IR Homeostatic Model Assessment for Insulin Resistance version 2.